1. Omacor® (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia

   • Heinz Rupp

   Review 27 July 2009 Pages: 675 - 690

2. Indacaterol, a novel inhaled, once-daily, long-acting beta₂-agonist for the treatment of obstructive airways diseases

   • Kai M. Beeh
   • Jutta Beier

   Review 16 July 2009 Pages: 691 - 699

3. Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension

   • Graziano Riccioni
   • Nicola Vitulano
   • Fulvio Bellocci

   Review 27 July 2009 Pages: 700 - 710

4. Dyslipidemia therapy update: the importance of full lipid profile assessment

   • I. B. A. Menown
   • G. Murtagh
   • G. Tomkin

   Review 27 July 2009 Pages: 711 - 718

5. Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial

   • Regina Busch
   • Hans-Joachim Graubaum
   • Jan Faergemann

   Original Research 27 July 2009 Pages: 719 - 727

6. Comparing hydrocortisone and methylprednisolone in patients with septic shock

   • Teng-Jen Yu
   • Yu-Chih Liu
   • Huang-Pin Wu

   Original Research 23 July 2009 Pages: 728 - 735

7. Erratum to: Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus

   • Abd A. Tahrani
   • Milan K. Piya
   • Anthony H. Barnett

   Erratum 01 August 2009 Pages: 736 - 736

8. Erratum to: Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis

   • Kit N. Simpson
   • Mary Jane Welch
   • Ziad Nahas

   Erratum 01 August 2009 Pages: 737 - 737